No patient left behind: making the impossible possible for clinical trials during adversity

With Andy Lee, head of global clinical trial operations

Running a massive clinical trials operation during a pandemic can be challenging. But Merck remains committed to making the impossible possible for the many patients in clinical trials.

Listen as Andy discusses the company’s commitment to and appreciation of patients – our partners in research – and some of the approaches we are taking to ensure that they are able to continue in the trial and as part of the research.



We have...



~400

studies


~50,000

participants in our trials


450M

data points processed each year


14,000

sites